We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
-5.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$25.3B
AUM Growth
-$2.07B
Cap. Flow
-$344M
Cap. Flow %
-1.36%
Top 10 Hldgs %
42.44%
Holding
294
New
5
Increased
61
Reduced
122
Closed
16

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$48.2M
2
XOM icon
ExxonMobil
XOM
+$17.9M
3
HES
Hess
HES
+$13.5M
4
V icon
Visa
V
+$13.2M
5
EOG icon
EOG Resources
EOG
+$7.08M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$57M
2
TTE icon
TotalEnergies
TTE
+$47.8M
3
AAPL icon
Apple
AAPL
+$41.4M
4
K
Kellanova
K
+$40.6M
5
OGN icon
Organon & Co
OGN
+$33.7M

Sector Composition

Rank Sector Weight
1 Technology 21.28%
2 Consumer Staples 19.28%
3 Financials 18.16%
4 Energy 12.21%
5 Healthcare 11.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
126
Gilead Sciences
GILD
$182B
$2.77M 0.01%
44,985
-971
-2% -$61.2K
BTI icon
127
British American Tobacco
BTI
$123B
$2.74M 0.01%
77,250
ORCL icon
128
Oracle
ORCL
$417B
$2.58M 0.01%
42,291
-1,770
-4% -$130K
OKE icon
129
Oneok
OKE
$61.1B
$2.57M 0.01%
50,177
CCI icon
130
Crown Castle
CCI
$31.6B
$2.56M 0.01%
17,742
-268
-1% -$45.9K
EQIX icon
131
Equinix
EQIX
$98.5B
$2.52M 0.01%
4,423
FOXA icon
132
Fox Class A
FOXA
$28.8B
$2.5M 0.01%
81,313
-35,522
-30% -$1.2M
DE icon
133
Deere & Co
DE
$184B
$2.3M 0.01%
6,887
+600
+10% +$206K
NSC icon
134
Norfolk Southern
NSC
$71.9B
$2.23M 0.01%
10,644
-200
-2% -$48.1K
DHR icon
135
Danaher
DHR
$143B
$2.15M 0.01%
9,402
+339
+4% +$83K
PAYX icon
136
Paychex
PAYX
$42.2B
$2.08M 0.01%
18,521
-307
-2% -$38K
EMR icon
137
Emerson Electric
EMR
$82.7B
$2M 0.01%
27,362
-2,629
-9% -$218K
BIIB icon
138
Biogen
BIIB
$32.1B
$1.98M 0.01%
7,413
CSCO icon
139
Cisco
CSCO
$434B
$1.94M 0.01%
48,557
-126,277
-72% -$5.6M
TMO icon
140
Thermo Fisher Scientific
TMO
$227B
$1.89M 0.01%
3,718
+1,378
+59% +$771K
CSX icon
141
CSX Corp
CSX
$90.6B
$1.88M 0.01%
70,404
FOX icon
142
Fox Class B
FOX
$25.7B
$1.85M 0.01%
64,857
-31,249
-33% -$980K
CVS icon
143
CVS Health
CVS
$122B
$1.84M 0.01%
19,262
-418
-2% -$41.4K
RL icon
144
Ralph Lauren
RL
$20.3B
$1.77M 0.01%
20,900
IFF icon
145
International Flavors & Fragrances
IFF
$21.3B
$1.73M 0.01%
19,094
+75
+0.4% +$8.59K
GIS icon
146
General Mills
GIS
$19.5B
$1.66M 0.01%
21,622
+213
+1% +$16.2K
LOW icon
147
Lowe's Companies
LOW
$111B
$1.65M 0.01%
8,793
-1,980
-18% -$386K
TSLA icon
148
Tesla
TSLA
$1.42T
$1.65M 0.01%
6,213
-618
-9% -$173K
FCX icon
149
Freeport-McMoran
FCX
$99.6B
$1.64M 0.01%
60,140
+30
+0% +$878
REGN icon
150
Regeneron Pharmaceuticals
REGN
$81.7B
$1.62M 0.01%
2,350

Similar funds

Fayez Sarofim & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Fayez Sarofim & Co held 294 positions worth $25.3B, down 7.6% from $27.4B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co's Q3 2022 filing shows 5 new, 61 increased, 122 reduced and 16 closed positions. Its largest new stake was Toyota: 1,680 shares worth $219K. The largest sale was Alphabet (Google) Class C, an estimated $57M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Financials.

  • Fayez Sarofim & Co's largest Q3 2022 buy was Toyota: 1,680 shares worth $219K.
  • Fayez Sarofim & Co added most to Novo Nordisk in Q3 2022, an estimated $48.2M increase.
  • Fayez Sarofim & Co's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $57M.
  • Fayez Sarofim & Co fully exited J.M. Smucker in Q3 2022, selling an estimated $4.69M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $25.3B portfolio in Q3 2022.
  • Fayez Sarofim & Co opened 5 new positions and closed 16 in Q3 2022.
  • Fayez Sarofim & Co's portfolio value fell 7.6% quarter-over-quarter to $25.3B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2022, filed 15 Nov 2022.